Chemotherapy and Radiation Therapy for the Treatment of IDH Wildtype Gliomas or Non-histological (Molecular) Glioblastomas

Abroad (travel likely)RecruitingPHASE2

Conditions

Anaplastic Astrocytoma, IDH-Wildtype · Anaplastic Oligoastrocytoma · Anaplastic Oligodendroglioma · Diffuse Astrocytoma, IDH-Wildtype · Glioblastoma · Oligoastrocytoma · Oligodendroglioma · WHO Grade II Glioma · WHO Grade III Glioma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

M D Anderson Cancer Center, Houston, Texas, United States
Contact: Study coordinator (Debra N. Yeboa) · 713-563-2300
Contact: Principal Investigator (Debra N. Yeboa)

Study leads

Debra N Yeboa
Principal Investigator
M.D. Anderson Cancer Center

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Retifanlimab With or Without Difluoromethylornithine for the Treatment of Progressive High Grade Gliomas

Anaplastic Oligodendroglioma · Astrocytoma, IDH-Mutant, Grade 3 · Astrocytoma, IDH-Mutant, Grade 4

Abroad (travel likely)RecruitingPHASE1, PHASE2

Rochester, United States

A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma

Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype · Astrocytoma, Grade III

Abroad (travel likely)RecruitingPHASE1, PHASE2

Chicago, United States · New York, United States

The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201)

Glioblastoma · High-grade Glioma · Glioblastoma, IDH-wildtype

Abroad (travel likely)Recruiting

San Francisco, United States · Boston, United States